Updated definitions of healthy ranges for serum alanine aminotransferase levels

Annals of Internal Medicine

Volumn 137, Issue 1, 2002, Pages 1-9

  Prati, Daniele ^a   Taioli, Emanuela ^a   Zanella, Alberto ^a   Della Torre, Emanuela ^a   Butelli, Sonia ^a   Del Vecchio, Emanuela ^a   Vianello, Luciana ^a   Zanuso, Francesco ^a   Mozzi, Fulvio ^a   Milani, Silvano ^a   Conte, Dario ^a   Colombo, Massimo ^a   Sirchia, Girolamo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; MALE; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; RELIABILITY;

EID: 0037008087     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-1-200207020-00006     Document Type: Article

References (39)

1. Evaluation of abnormal liver-enzyme results in asymptomatic patients
2. Diagnostic approach to liver enzyme elevation
3. Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay
4. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection
5. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
6. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
7. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
8. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
9. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients
10. Nonalcoholic steatoheparitis
11. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors
12. Blood donors with "medium" or "minor" risk factors for human immunodeficiency virus infection: Are they eligible for donation?
13. Asymptomatic hepatitis G virus infection in blood donors
14. Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C
15. La gestione automatizzata del Centro Trasfusionale e di Immunologia dei Trapianti del Policlinico di Milano
16. Guidelines for healthy weight
17. The meaning and use of the area under a receiver operating characteristic (ROC) curve
18. Classification of chronic hepatitis: Diagnosis, grading and staging
19. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy
20. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study
21. Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C
22. Persistent alanine aminotransferase elevation in healthy Swedish blood donors - Mainly caused by obesity
23. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women
24. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
25. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study
26. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
27. Nonalcoholic steatohepatitis and the "bright liver syndrome": Should a recently expanded clinical entity be further expanded?
28. Prevalence of and risk factors for hepatic steatosis in Northern Italy
29. Clinical features and natural history of nonalcoholic steatosis syndromes
30. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
31. Liver fibrosis in overweight patients
32. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
33. Body composition and hepatic steatosis as precursors for fibrotic liver disease
34. Body-mass index and mortality in a prospective cohort of U.S. adults
35. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
36. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
37. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
38. Post-transfusion hepatitis: Impact of non-A, non-B hepatitis surrogate tests
39. Infectious disease testing for blood transfusions